South Korea Biotechnology & Medical Research

Orum Therapeutics, Inc. (475830)

Orum Therapeutics recorded a single insider purchase during the past ninety days. Representative Director Lee Sung Joo acquired shares valued at 171.76 million KRW on October 23, 2026. This transaction occurred amidst a period where the stock price declined by 64.6 percent, though no recent earnings report provides additional context regarding these equity movements.

No insider activity signal

Top insider buys (90, 60, 30d)

Top executive buys (90, 60, 30d)

Featured in screeners

No insider activity signal

Top insider buys

Top executive buys

Ticker: 475830 Exchange: KOE

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Insider activity signals

0 activity signals detected for Orum Therapeutics, Inc.

No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

Lee Sung Joo (이승주) Representative Director (대표이사) Executive Director

Transaction date 23 Oct 2026

Purchase

Price

277.08

Quantity 93,284 -5.9%

Value ₩4,686,029

Comments Filing

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value	Details
2026-10-29	2026-10-23	B Purchase	Lee Sung Joo (이승주) Representative Director (대표이사) Executive Director	93,284 -5.9% 277.08 ₩4,686,029	93,284 -5.9%	277.08	₩4,686,029